In this study, we provided a potential gene regulation mechanism under CHIP-dependent altered chromatin activities, but the characterization of chromatin status was limited to AML patients carrying DNMT3A CHIP mutations. This evidence concerns the gene STUB1 and acute myeloid leukemia.